APO Research
Talk to an analyst

APO RESEARCH · REPORT

N-Acetylglutamate Synthetase Deficiency (NAGSD)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025186 pages

Choose your research edition.

Industry ResearchN-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal N-Acetylglutamate Synthetase Deficiency (NAGSD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global N-Acetylglutamate Synthetase Deficiency (NAGSD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of N-Acetylglutamate Synthetase Deficiency (NAGSD) include Grand Pharmaceutical Group, Lee's Pharmaceuticals, Sovereign Medical, Sigmapharm Laboratories, Recordati Rare Diseases, Medunik, Immedica, Amgen and Acer Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of N-Acetylglutamate Synthetase Deficiency (NAGSD) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents N-Acetylglutamate Synthetase Deficiency (NAGSD) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the N-Acetylglutamate Synthetase Deficiency (NAGSD) market size, projected growth trends, production technologies, key applications, and end-use industries.

N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Company

Grand Pharmaceutical Group

Lee's Pharmaceuticals

Sovereign Medical

Sigmapharm Laboratories

Recordati Rare Diseases

Medunik

Immedica

Amgen

Acer Therapeutics

N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Type

Original Drug

Generic Drug

N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Application

Adults

Children

N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of N-Acetylglutamate Synthetase Deficiency (NAGSD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of N-Acetylglutamate Synthetase Deficiency (NAGSD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of N-Acetylglutamate Synthetase Deficiency (NAGSD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global N-Acetylglutamate Synthetase Deficiency (NAGSD) industry.

Chapter 3: Detailed analysis of N-Acetylglutamate Synthetase Deficiency (NAGSD) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, N-Acetylglutamate Synthetase Deficiency (NAGSD)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Original Drug Table 3. Key Players of Generic Drug Table 4. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Adults Table 6. Key Players of Children Table 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026) & (US$ Million) Table 9. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2021-2026) Table 10. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2027-2032) & (US$ Million) Table 11. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2027-2032) Table 12. N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Trends Table 13. N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Drivers Table 14. N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Opportunities and Challenges Table 15. N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Restraints Table 16. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Company (US$ Million) & (2021-2026) Table 17. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Company (2021-2026) Table 18. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Key Company Head Office and Area Served Table 20. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Company, Product Type & Application Table 21. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & (US$ Million) Table 26. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032) & (US$ Million) Table 27. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Type (2021-2026) Table 28. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Type (2027-2032) Table 29. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & (US$ Million) Table 31. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032) & (US$ Million) Table 32. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Application (2021-2026) Table 33. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Application (2027-2032) Table 34. Grand Pharmaceutical Group Company Information Table 35. Grand Pharmaceutical Group Business Overview Table 36. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 38. Grand Pharmaceutical Group Recent Development Table 39. Lee's Pharmaceuticals Company Information Table 40. Lee's Pharmaceuticals Business Overview Table 41. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 43. Lee's Pharmaceuticals Recent Development Table 44. Sovereign Medical Company Information Table 45. Sovereign Medical Business Overview Table 46. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 48. Sovereign Medical Recent Development Table 49. Sigmapharm Laboratories Company Information Table 50. Sigmapharm Laboratories Business Overview Table 51. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 53. Sigmapharm Laboratories Recent Development Table 54. Recordati Rare Diseases Company Information Table 55. Recordati Rare Diseases Business Overview Table 56. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 58. Recordati Rare Diseases Recent Development Table 59. Medunik Company Information Table 60. Medunik Business Overview Table 61. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 63. Medunik Recent Development Table 64. Immedica Company Information Table 65. Immedica Business Overview Table 66. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 68. Immedica Recent Development Table 69. Amgen Company Information Table 70. Amgen Business Overview Table 71. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 73. Amgen Recent Development Table 74. Acer Therapeutics Company Information Table 75. Acer Therapeutics Business Overview Table 76. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 78. Acer Therapeutics Recent Development Table 79. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & (US$ Million) Table 80. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032) & (US$ Million) Table 81. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & (US$ Million) Table 82. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032) & (US$ Million) Table 83. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) Table 85. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027-2032) Table 86. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & (US$ Million) Table 87. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032) & (US$ Million) Table 88. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & (US$ Million) Table 89. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032) & (US$ Million) Table 90. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) Table 92. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027-2032) Table 93. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & (US$ Million) Table 94. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032) & (US$ Million) Table 95. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & (US$ Million) Table 96. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & (US$ Million) Table 98. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032) & (US$ Million) Table 99. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & (US$ Million) Table 100. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032) & (US$ Million) Table 101. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) Table 103. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027-2032) Table 104. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & (US$ Million) Table 105. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032) & (US$ Million) Table 106. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & (US$ Million) Table 107. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032) & (US$ Million) Table 108. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) Table 110. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027-2032) Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Image Figure 2. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type: 2025 VS 2032 Figure 4. Original Drug Image Figure 5. Generic Drug Image Figure 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application: 2025 VS 2032 Figure 8. Adults Image Figure 9. Children Image Figure 10. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 12. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Players in 2025 Figure 15. Global Top 5 and 10 N-Acetylglutamate Synthetase Deficiency (NAGSD) Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Type (2021-2032) Figure 19. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Application (2021-2032) Figure 21. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 22. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032) Figure 23. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032) Figure 24. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032) Figure 25. United States N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 26. Canada N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 27. Mexico N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 28. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 29. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032) Figure 30. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032) Figure 31. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032) Figure 32. Germany N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 33. France N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 34. U.K. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 35. Italy N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 36. Russia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 38. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 39. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032) Figure 40. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032) Figure 41. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 42. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032) Figure 43. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032) Figure 44. Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032) Figure 45. Japan N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 46. South Korea N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 49. India N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 50. Australia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032) Figure 55. Brazil N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 56. South Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 58. Turkey N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 59. Argentina N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 60. UAE N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 61. Egypt N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 62. Chile N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Adults
  • Children
Companies covered
  • Grand Pharmaceutical Group
  • Lee's Pharmaceuticals
  • Sovereign Medical
  • Sigmapharm Laboratories
  • Recordati Rare Diseases
  • Medunik
  • Immedica
  • Amgen
  • Acer Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Original Drug
  5. 1.2.3 Generic Drug
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Adults
  9. 1.3.3 Children
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Growth Trends by Region
  12. 1.5.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026)
  14. 1.5.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Dynamics
  1. 2.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Trends
  2. 2.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Drivers
  3. 2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Opportunities and Challenges
  4. 2.4 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Company (2021-2026)
  2. 3.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Key Company Head office and Area Served
  4. 3.4 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Company, Product Type & Application
  5. 3.5 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 N-Acetylglutamate Synthetase Deficiency (NAGSD) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 N-Acetylglutamate Synthetase Deficiency (NAGSD) Tier 1, Tier 2, and Tier 3
4 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market by Type
  1. 4.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2032)
  3. 4.3 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Type (2021-2032)
5 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market by Application
  1. 5.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2032)
  3. 5.3 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Grand Pharmaceutical Group
  2. 6.1.1 Grand Pharmaceutical Group Company Information
  3. 6.1.2 Grand Pharmaceutical Group Business Overview
  4. 6.1.3 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  6. 6.1.5 Grand Pharmaceutical Group Recent Developments
  7. 6.2 Lee's Pharmaceuticals
  8. 6.2.1 Lee's Pharmaceuticals Company Information
  9. 6.2.2 Lee's Pharmaceuticals Business Overview
  10. 6.2.3 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  12. 6.2.5 Lee's Pharmaceuticals Recent Developments
  13. 6.3 Sovereign Medical
  14. 6.3.1 Sovereign Medical Company Information
  15. 6.3.2 Sovereign Medical Business Overview
  16. 6.3.3 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  18. 6.3.5 Sovereign Medical Recent Developments
  19. 6.4 Sigmapharm Laboratories
  20. 6.4.1 Sigmapharm Laboratories Company Information
  21. 6.4.2 Sigmapharm Laboratories Business Overview
  22. 6.4.3 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  24. 6.4.5 Sigmapharm Laboratories Recent Developments
  25. 6.5 Recordati Rare Diseases
  26. 6.5.1 Recordati Rare Diseases Company Information
  27. 6.5.2 Recordati Rare Diseases Business Overview
  28. 6.5.3 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  30. 6.5.5 Recordati Rare Diseases Recent Developments
  31. 6.6 Medunik
  32. 6.6.1 Medunik Company Information
  33. 6.6.2 Medunik Business Overview
  34. 6.6.3 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  36. 6.6.5 Medunik Recent Developments
  37. 6.7 Immedica
  38. 6.7.1 Immedica Company Information
  39. 6.7.2 Immedica Business Overview
  40. 6.7.3 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  42. 6.7.5 Immedica Recent Developments
  43. 6.8 Amgen
  44. 6.8.1 Amgen Company Information
  45. 6.8.2 Amgen Business Overview
  46. 6.8.3 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  48. 6.8.5 Amgen Recent Developments
  49. 6.9 Acer Therapeutics
  50. 6.9.1 Acer Therapeutics Company Information
  51. 6.9.2 Acer Therapeutics Business Overview
  52. 6.9.3 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  54. 6.9.5 Acer Therapeutics Recent Developments
7 North America
  1. 7.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032)
  2. 7.2 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type
  3. 7.2.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
  4. 7.2.2 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032)
  5. 7.2.3 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032)
  6. 7.3 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application
  7. 7.3.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
  8. 7.3.2 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032)
  9. 7.3.3 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032)
  10. 7.4 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country
  11. 7.4.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
  13. 7.4.3 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027-2032)
  14. 7.4.4 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032)
  2. 8.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type
  3. 8.2.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
  4. 8.2.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032)
  5. 8.2.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032)
  6. 8.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application
  7. 8.3.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
  8. 8.3.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032)
  9. 8.3.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032)
  10. 8.4 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country
  11. 8.4.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
  13. 8.4.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027-2032)
  14. 8.4.4 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032)
  2. 9.2 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type
  3. 9.2.1 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
  4. 9.2.2 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032)
  5. 9.2.3 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032)
  6. 9.3 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application
  7. 9.3.1 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
  8. 9.3.2 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032)
  9. 9.3.3 China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032)
  2. 10.2 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type
  3. 10.2.1 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
  4. 10.2.2 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032)
  5. 10.2.3 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032)
  6. 10.3 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application
  7. 10.3.1 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
  8. 10.3.2 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032)
  9. 10.3.3 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032)
  10. 10.4 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country
  11. 10.4.1 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
  13. 10.4.3 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027-2032)
  14. 10.4.4 Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst